Obesity is highly associated with type 2 diabetes mellitus (T2DM), both of which can be simultaneously treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs). The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.